Differential Cav2.1 and Cav2.3 channel inhibition by baclofen and α-conotoxin Vc1.1 via GABAB receptor activation

Journal of General Physiology

Volumn 143, Issue 4, 2014, Pages 465-479

  Berecki, Géza ^a   McArthur, Jeffrey R ^a   Cuny, Hartmut ^a   Clark, Richard J ^b   Adams, David J ^a  

^a RMIT UNIVERSITY   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR STIMULATING AGENT; ALPHA-CONOTOXIN VC1.1; BACLOFEN; CACNA1E PROTEIN, HUMAN; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL N TYPE; CALCIUM CHANNEL R TYPE; CATION TRANSPORT PROTEIN; CONOTOXIN; VOLTAGE-DEPENDENT CALCIUM CHANNEL (P-Q TYPE);

AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; COMPARATIVE STUDY; DOSE RESPONSE; GENETICS; HEK293 CELL LINE; HUMAN; METABOLISM; MOLECULAR GENETICS; RAT;

AMINO ACID SEQUENCE; ANIMALS; BACLOFEN; CALCIUM CHANNEL BLOCKERS; CALCIUM CHANNELS, N-TYPE; CALCIUM CHANNELS, R-TYPE; CATION TRANSPORT PROTEINS; CONOTOXINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABA-B RECEPTOR AGONISTS; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; RATS; RECEPTORS, GABA-B;

EID: 84899956918     PISSN: 00221295     EISSN: 15407748     Source Type: Journal    
DOI: 10.1085/jgp.201311104     Document Type: Article

References (68)

1. Adams, D.J., and G. Berecki, 2013. Mechanisms of conotoxin inhibition of N-type (Cav2.2) calcium channels. Biochim. Biophys. Acta, 1828:1619-1628. http://dx.doi.org/10.1016/j.bbamem.2013.01.019
2. Altier, C., and G.W. Zamponi, 2004. Targeting Ca2+ channels to treat pain: T-type versus N-type. Trends Pharmacol. Sci. 25:465-470. http://dx.doi.org/10.1016/j.tips.2004.07.004
3. Altier, C., C.S. Dale, A.E. Kisilevsky, K. Chapman, A.J. Castiglioni, E.A. Matthews, R.M. Evans, A.H. Dickenson, D. Lipscombe, N. Vergnolle, and G.W. Zamponi, 2007. Differential role of N-type calcium channel splice isoforms in pain. J. Neurosci. 27:6363-6373. http://dx.doi.org/10.1523/JNEUROSCI.0307-07.2007
4. Amanchy, R., B. Periaswamy, S. Mathivanan, R. Reddy, S.G. Tattikota, and A. Pandey, 2007. A curated compendium of phosphorylation motifs. Nat. Biotechnol. 25:285-286. http://dx.doi.org/10.1038/nbt0307-285
5. Bannister, R.A., K. Melliti, and B.A. Adams, 2004. Differential modulation of CaV2.3 Ca2+ channels by Gαq/11-coupled muscarinic receptors. Mol. Pharmacol. 65:381-388. http://dx.doi.org/10.1124/mol.65.2.381
6. Bean, B.P, 1989. Neurotransmitter inhibition of neuronal calcium currents by changes in channel voltage dependence. Nature. 340:153-156. http://dx.doi.org/10.1038/340153a0
7. Bell, T.J., C. Thaler, A.J. Castiglioni, T.D. Helton, and D. Lipscombe, 2004. Cell-specific alternative splicing increases calcium channel current density in the pain pathway. Neuron. 41:127-138. http://dx.doi.org/10.1016/S0896-6273(03)00801-8
8. Bence, K., W. Ma, T. Kozasa, and X.Y. Huang, 1997. Direct stimulation of Bruton's tyrosine kinase by Gq-protein α-subunit. Nature. 389:296-299. http://dx.doi.org/10.1038/38520
9. Bourinet, E., T.W. Soong, A. Stea, and T.P. Snutch, 1996. Determinants of the G protein-dependent opioid modulation of neuronal calcium channels. Proc. Natl. Acad. Sci. USA. 93:1486-1491. http://dx.doi.org/10.1073/pnas.93.4.1486
10. Bourinet, E., T.W. Soong, K. Sutton, S. Slaymaker, E. Mathews, A. Monteil, G.W. Zamponi, J. Nargeot, and T.P. Snutch, 1999. Splicing of α1A subunit gene generates phenotypic variants of P- and Q-type calcium channels. Nat. Neurosci. 2:407-415. http://dx.doi.org/10.1038/8070
11. Bowery, N.G, 2010. Historical perspective and emergence of the GABAB receptor. Adv. Pharmacol. 58:1-18. http://dx.doi.org/10.1016/S1054-3589(10)58001-3
12. Callaghan, B., and D.J. Adams, 2010. Analgesic α-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in sensory neurons of α9 nicotinic receptor knockout mice. Channels (Austin). 4:1-4.
13. Callaghan, B., A. Haythornthwaite, G. Berecki, R.J. Clark, D.J. Craik, and D.J. Adams, 2008. Analgesic α-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. J. Neurosci. 28:10943-10951. http://dx.doi.org/10.1523/JNEUROSCI.3594-08.2008
14. Chieng, B., and J.M. Bekkers, 1999. GABAB, opioid and α2 receptor inhibition of calcium channels in acutely-dissociated locus coeruleus neurones. Br. J. Pharmacol. 127:1533-1538. http://dx.doi.org/10.1038/sj.bjp.0702693
15. Christopoulos, A., and T. Kenakin, 2002. G protein-coupled receptor allosterism and complexing. Pharmacol. Rev. 54:323-374. http://dx.doi.org/10.1124/pr.54.2.323
16. Clark, R.J., H. Fischer, S.T. Nevin, D.J. Adams, and D.J. Craik, 2006. The synthesis, structural characterization, and receptor specificity of the α-conotoxin Vc1.1. J. Biol. Chem. 281:23254-23263. http://dx.doi.org/10.1074/jbc. M604550200
17. Clark, R.J., J. Jensen, S.T. Nevin, B.P. Callaghan, D.J. Adams, and D.J. Craik, 2010. The engineering of an orally active conotoxin for the treatment of neuropathic pain. Angew. Chem. Int. Ed. Engl. 49:6545-6548. http://dx.doi.org/10.1002/anie.201000620
18. Cox, D.H., and K. Dunlap, 1992. Pharmacological discrimination of N-type from L-type calcium current and its selective modulation by transmitters. J. Neurosci. 12:906-914.
19. Cuny, H., A. de Faoite, T.G. Huynh, T. Yasuda, G. Berecki, and D.J. Adams, 2012. α-Aminobutyric acid type B (GABAB) receptor expression is needed for inhibition of N-type (Cav2.2) calcium channels by analgesic α-conotoxins. J. Biol. Chem. 287:23948-23957. http://dx.doi.org/10.1074/jbc. M112.342998
20. Currie, K.P., and A.P. Fox, 1997. Comparison of N- and P/Q-type voltage-gated calcium channel current inhibition. J. Neurosci. 17:4570-4579.
21. Dai, G., R.J. Haedo, V.A. Warren, K.S. Ratliff, R.M. Bugianesi, A. Rush, M.E. Williams, J. Herrington, M.M. Smith, O.B. McManus, and A.M. Swensen, 2008. A high-throughput assay for evaluating state dependence and subtype selectivity of Cav2 calcium channel inhibitors. Assay Drug Dev. Technol. 6:195-212. http://dx.doi.org/10.1089/adt.2008.136
22. Daly, N.L., B. Callaghan, R.J. Clark, S.T. Nevin, D.J. Adams, and D.J. Craik, 2011. Structure and activity of α-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABAB receptorcoupled N-type calcium channels. J. Biol. Chem. 286:10233-10237. http://dx.doi.org/10.1074/jbc. M110.196170
23. Delmas, P., B. Coste, N. Gamper, and M.S. Shapiro, 2005. Phos phoinositide lipid second messengers: New paradigms for calcium channel modulation. Neuron. 47:179-182. http://dx.doi.org/10.1016/j.neuron.2005.07.001
24. Diverse-Pierluissi, M., A.E. Remmers, R.R. Neubig, and K. Dunlap, 1997. Novel form of crosstalk between G protein and tyrosine kinase pathways. Proc. Natl. Acad. Sci. USA. 94:5417-5421. http://dx.doi.org/10.1073/pnas.94.10.5417
25. Dolphin, A.C., and R.H. Scott, 1986. Inhibition of calcium currents in cultured rat dorsal root ganglion neurones by (α)-baclofen. Br. J. Pharmacol. 88:213-220. http://dx.doi.org/10.1111/j.1476-5381.1986.tb09489.x
26. Dubuis, E., N. Rockliffe, M. Hussain, M. Boyett, D. Wray, and D. Gawler, 2006. Evidence for multiple Src binding sites on the α1c L-type Ca2+ channel and their roles in activity regulation. Cardiovasc. Res. 69:391-401. http://dx.doi.org/10.1016/j.cardiores.2005.11.006
27. Fang, Z., C.K. Park, H.Y. Li, H.Y. Kim, S.H. Park, S.J. Jung, J.S. Kim, A. Monteil, S.B. Oh, and R.J. Miller, 2007. Molecular basis of Cav2.3 calcium channels in rat nociceptive neurons. J. Biol. Chem. 282:4757-4764. http://dx.doi.org/10.1074/jbc. M605248200
28. Fang, Z., J.H. Hwang, J.S. Kim, S.J. Jung, and S.B. Oh, 2010. R-type calcium channel isoform in rat dorsal root ganglion neurons. Korean J. Physiol. Pharmacol. 14:45-49. http://dx.doi.org/10.4196/kjpp.2010.14.1.45
29. Favre, I., E. Moczydlowski, and L. Schild, 1995. Specificity for block by saxitoxin and divalent cations at a residue which determines sensitivity of sodium channel subtypes to guanidinium toxins. J. Gen. Physiol. 106:203-229. http://dx.doi.org/10.1085/jgp.106.2.203
30. Gao, J., K.E. Zoller, M.H. Ginsberg, J.S. Brugge, and S.J. Shattil, 1997. Regulation of the pp72syk protein tyrosine kinase by platelet integrin αIIbα3. EMBO J. 16:6414-6425. http://dx.doi.org/10.1093/emboj/16.21.6414
31. Gasparini, S., A.M. Kasyanov, D. Pietrobon, L.L. Voronin, and E. Cherubini, 2001. Presynaptic R-type calcium channels contribute to fast excitatory synaptic transmission in the rat hippocampus. J. Neurosci. 21:8715-8721.
32. Gray, A.C., J. Raingo, and D. Lipscombe, 2007. Neuronal calcium channels: Splicing for optimal performance. Cell Calcium. 42:409-417. http://dx.doi.org/10.1016/j.ceca.2007.04.003
33. Guyon, A., and N. Leresche, 1995. Modulation by different GABAB receptor types of voltage-activated calcium currents in rat thalamocortical neurones. J. Physiol. 485:29-42.
34. Jordan, M., A. Schallhorn, and F.M. Wurm, 1996. Transfecting mammalian cells: Optimization of critical parameters affecting calcium-phosphate precipitate formation. Nucleic Acids Res. 24:596-601. http://dx.doi.org/10.1093/nar/24.4.596
35. Kasai, H., and T. Aosaki, 1989. Modulation of Ca-channel current by an adenosine analog mediated by a GTP-binding protein in chick sensory neurons. Pflugers Arch. 414:145-149. http://dx.doi.org/10.1007/BF00580956
36. Klimis, H., D.J. Adams, B. Callaghan, S. Nevin, P.F. Alewood, C.W. Vaughan, C.A. Mozar, and M.J. Christie, 2011. A novel mechanism of inhibition of high-voltage activated calcium channels by α-conotoxins contributes to relief of nerve injury-induced neuropathic pain. Pain. 152:259-266. http://dx.doi.org/10.1016/j.pain.2010.09.007
37. Lambert, N.A., and W.A. Wilson, 1996. High-threshold Ca2+ currents in rat hippocampal interneurones and their selective inhibition by activation of GABAB receptors. J. Physiol. 492:115-127.
38. Lipscombe, D., S. Kongsamut, and R.W. Tsien, 1989. α-Adrenergic inhibition of sympathetic neurotransmitter release mediated by modulation of N-type calcium-channel gating. Nature. 340:639-642. http://dx.doi.org/10.1038/340639a0
39. Luebke, J.I., K. Dunlap, and T.J. Turner, 1993. Multiple calcium channel types control glutamatergic synaptic transmission in the hippocampus. Neuron. 11:895-902. http://dx.doi.org/10.1016/0896-6273(93)90119-C
40. Luttrell, L.M., S.S. Ferguson, Y. Daaka, W.E. Miller, S. Maudsley, G.J. Della Rocca, F. Lin, H. Kawakatsu, K. Owada, D.K. Luttrell, et al, 1999. α-Arrestin-dependent formation of α2 adrenergic receptor-Src protein kinase complexes. Science. 283:655-661. http://dx.doi.org/10.1126/science.283.5402.655
41. Matthews, E.A., L.A. Bee, G.J. Stephens, and A.H. Dickenson, 2007. The Cav2.3 calcium channel antagonist SNX-482 reduces dorsal horn neuronal responses in a rat model of chronic neuropathic pain. Eur. J. Neurosci. 25:3561-3569. http://dx.doi.org/10.1111/j.1460-9568.2007.05605.x
42. McIntosh, J.M., N. Absalom, M. Chebib, A.B. Elgoyhen, and M. Vincler, 2009. α9 nicotinic acetylcholine receptors and the treatment of pain. Biochem. Pharmacol. 78:693-702. http://dx.doi.org/10.1016/j.bcp.2009.05.020
43. Mehrke, G., A. Pereverzev, H. Grabsch, J. Hescheler, and T. Schneider, 1997. Receptor-mediated modulation of recombinant neuronal class E calcium channels. FEBS Lett. 408:261-270. http://dx.doi.org/10.1016/S0014-5793(97)00437-7
44. Mintz, I.M., and B.P. Bean, 1993. GABAB receptor inhibition of P-type Ca2+ channels in central neurons. Neuron. 10:889-898. http://dx.doi.org/10.1016/0896-6273(93)90204-5
45. Ottolia, M., D. Platano, N. Qin, F. Noceti, M. Birnbaumer, L. Toro, L. Birnbaumer, E. Stefani, and R. Olcese, 1998. Functional coupling between human E-type Ca2+ channels and μ opioid receptors expressed in Xenopus oocytes. FEBS Lett. 427:96-102. http://dx.doi.org/10.1016/S0014-5793(98)00401-3
46. Page, K.M., C. Canti, G.J. Stephens, N.S. Berrow, and A.C. Dolphin, 1998. Identification of the amino terminus of neuronal Ca2+ channel α1 subunits α1B and α1E as an essential determinant of G-protein modulation. J. Neurosci. 18:4815-4824.
47. Pan, H.L., Z.Z. Wu, H.Y. Zhou, S.R. Chen, H.M. Zhang, and D.P. Li, 2008. Modulation of pain transmission by G-protein-coupled receptors. Pharmacol. Ther. 117:141-161. http://dx.doi.org/10.1016/j.pharmthera.2007.09.003
48. Pawson, T., G.D. Gish, and P. Nash, 2001. SH2 domains, interaction modules and cellular wiring. Trends Cell Biol. 11:504-511. http://dx.doi.org/10.1016/S0962-8924(01)02154-7
49. Pereverzev, A., J. Leroy, A. Krieger, C.O. Malecot, J. Hescheler, G. Pfitzer, U. Klockner, and T. Schneider, 2002. Alternate splicing in the cytosolic II-III loop and the carboxy terminus of human E-type voltage-gated Ca2+ channels: Electrophysiological characterization of isoforms. Mol. Cell. Neurosci. 21:352-365. http://dx.doi.org/10.1006/mcne.2002.1179
50. Pexton, T., T. Moeller-Bertram, J.M. Schilling, and M.S. Wallace, 2011. Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development. Expert Opin. Investig. Drugs. 20:1277-1284. http://dx.doi.org/10.1517/13543784.2011.600686
51. Qian, A., D. Song, Y. Li, X. Liu, D. Tang, W. Yao, and Y. Yuan, 2013. Role of voltage gated Ca2+ channels in rat visceral hypersensitivity change induced by 2,4,6-trinitrobenzene sulfonic acid. Mol. Pain. 9:15. http://dx.doi.org/10.1186/1744-8069-9-15
52. Raingo, J., A.J. Castiglioni, and D. Lipscombe, 2007. Alternative splicing controls G protein-dependent inhibition of N-type calcium channels in nociceptors. Nat. Neurosci. 10:285-292. http://dx.doi.org/10.1038/nn1848
53. Saegusa, H., T. Kurihara, S. Zong, O. Minowa, A. Kazuno, W. Han, Y. Matsuda, H. Yamanaka, M. Osanai, T. Noda, and T. Tanabe, 2000. Altered pain responses in mice lacking α1E subunit of the voltage-dependent Ca2+ channel. Proc. Natl. Acad. Sci. USA. 97:6132-6137. http://dx.doi.org/10.1073/pnas.100124197
54. Schiff, M.L., D.P. Siderovski, J.D. Jordan, G. Brothers, B. Snow, L. De Vries, D.F. Ortiz, and M. Diverse-Pierluissi, 2000. Tyrosine-kinasedependent recruitment of RGS12 to the N-type calcium channel. Nature. 408:723-727. http://dx.doi.org/10.1038/35047093
55. Schneider, T., X. Wei, R. Olcese, J.L. Costantin, A. Neely, P. Palade, E. Perez-Reyes, N. Qin, J. Zhou, G.D. Crawford, et al, 1994. Molecular analysis and functional expression of the human type E neuronal Ca2+ channel alpha 1 subunit. Receptors Channels. 2:255-270.
56. Schneider, T., M. Dibue, and J. Hescheler, 2013. How "Pharmacoresistant" is Cav2.3, the major component of voltage-gated R-type Ca2+ channels. Pharmaceuticals (Basel). 6:759-776. http://dx.doi.org/10.3390/ph6060759
57. Shekter, L.R., R. Taussig, S.E. Gillard, and R.J. Miller, 1997. Regulation of human neuronal calcium channels by G protein αα subunits expressed in human embryonic kidney 293 cells. Mol. Pharmacol. 52:282-291.
58. Simen, A.A., and R.J. Miller, 2000. Involvement of regions in domain I in the opioid receptor sensitivity of α1B Ca2+ channels. Mol. Pharmacol. 57:1064-1074.
59. Stephens, G.J., C. Canti, K.M. Page, and A.C. Dolphin, 1998. Role of domain I of neuronal Ca2+ channel α1 subunits in G protein modulation. J. Physiol. 509:163-169. http://dx.doi.org/10.1111/j.1469-7793.1998.163bo.x
60. Takahashi, T., and A. Momiyama, 1993. Different types of calcium channels mediate central synaptic transmission. Nature. 366:156-158. http://dx.doi.org/10.1038/366156a0
61. Terashima, T., Q. Xu, S. Yamaguchi, and T.L. Yaksh, 2013. Intrathecal P/Q- and R-type calcium channel blockade of spinal substance P release and c-Fos expression. Neuropharmacology. 75:1-8. http://dx.doi.org/10.1016/j.neuropharm.2013.06.018
62. Williams, M.E., L.M. Marubio, C.R. Deal, M. Hans, P.F. Brust, L.H. Philipson, R.J. Miller, E.C. Johnson, M.M. Harpold, and S.B. Ellis, 1994. Structure and functional characterization of neuronal α1E calcium channel subtypes. J. Biol. Chem. 269:22347-22357.
63. Wu, L.G., J.G. Borst, and B. Sakmann, 1998. R-type Ca2+ currents evoke transmitter release at a rat central synapse. Proc. Natl. Acad. Sci. USA. 95:4720-4725. http://dx.doi.org/10.1073/pnas.95.8.4720
64. Yokoyama, K., T. Kurihara, H. Saegusa, S. Zong, K. Makita, and T. Tanabe, 2004. Blocking the R-type (Cav2.3) Ca2+ channel enhanced morphine analgesia and reduced morphine tolerance. Eur. J. Neurosci. 20:3516-3519. http://dx.doi.org/10.1111/j.1460-9568.2004.03810.x
65. Yomiya, K., N. Matsuo, S. Tomiyasu, T. Yoshimoto, T. Tamaki, T. Suzuki, and M. Matoba, 2009. Baclofen as an adjuvant analgesic for cancer pain. Am. J. Hosp. Palliat. Care. 26:112-118. http://dx.doi.org/10.1177/1049909108327968
66. Zamponi, G.W., and K.P. Currie, 2013. Regulation of CaV2 calcium channels by G protein coupled receptors. Biochim. Biophys. Acta, 1828:1629-1643. http://dx.doi.org/10.1016/j.bbamem.2012.10.004
67. Zuhlke, R.D., G.S. Pitt, K. Deisseroth, R.W. Tsien, and H. Reuter, 1999. Calmodulin supports both inactivation and facilitation of L-type calcium channels. Nature. 399:159-162. http://dx.doi.org/10.1038/20200
68. Zuniga, R.E., C.R. Schlicht, and S.E. Abram, 2000. Intrathecal baclofen is analgesic in patients with chronic pain. Anesthesiology. 92:876-880. http://dx.doi.org/10.1097/00000542-200003000-00037